CTRI/2023/08/056234
Not Yet Recruiting
Phase 4
A Clinical Study to Evaluate the Safety and Efficacy of Panchakarma Essential in female patients with generalized anxiety disorder - NI
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Mprex Healthcare Pvt. Ltd.
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Female subjects 30\-60 years of age will be included.2\.Female subjects with no history of allergy to oils.3\.Be willing to refrain from taking any medication during or before the study for the said indication.
- •4\.An ambulatory female subject can provide verbal and written consent and is ready to comply with all study procedures.
Exclusion Criteria
- •1\. Female subjects with Depression, Social phobias, Hypertension, Cardiac diseases, Epilepsy, Asthma, Hyperthyroidism, Alcoholics, and Drug addicts
- •2\. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
Phase 2
Effect of Decoction of Cuscuta Reflexa and local application of Saussurea Lappa and Honey in the management of Melasma.CTRI/2021/03/032083Central Council of Research in Unani Medicine New Delhi
Not Yet Recruiting
Phase 4
To study the effect of Panchakarma Essential in male patients with anxiety.CTRI/2023/07/055723Mprex Healthcare Pvt. Ltd.
Not Yet Recruiting
Phase 4
To evaluate the Safety and Efficacy of ACELABS SerumCTRI/2024/02/063322Bright Diva Pte. Ltd.
Not Yet Recruiting
N/A
To study the effect of Panchakarma Essential in reducing symptoms with cardiopulmonarydisordersHealth Condition 1: I249- Acute ischemic heart disease, unspecifiedCTRI/2023/11/060197Mprex Healthcare Pvt.Ltd. Wakad, pune
Completed
Phase 2
TO Find the Effect of LION�S MANE CAPSULE as Nutritional SupplementHealth Condition 1: E089- Diabetes mellitus due to underlying condition without complicationsCTRI/2022/03/040725DXN Manufacturing India Pvt Ltd24